Literature DB >> 12032568

Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family.

Karl P Schlingmann1, Stefanie Weber, Melanie Peters, Lene Niemann Nejsum, Helga Vitzthum, Karin Klingel, Markus Kratz, Elie Haddad, Ellinor Ristoff, Dganit Dinour, Maria Syrrou, Søren Nielsen, Martin Sassen, Siegfried Waldegger, Hannsjörg W Seyberth, Martin Konrad.   

Abstract

Magnesium is an essential ion involved in many biochemical and physiological processes. Homeostasis of magnesium levels is tightly regulated and depends on the balance between intestinal absorption and renal excretion. However, little is known about specific proteins mediating transepithelial magnesium transport. Using a positional candidate gene approach, we identified mutations in TRPM6 (also known as CHAK2), encoding TRPM6, in autosomal-recessive hypomagnesemia with secondary hypocalcemia (HSH, OMIM 602014), previously mapped to chromosome 9q22 (ref. 3). The TRPM6 protein is a new member of the long transient receptor potential channel (TRPM) family and is highly similar to TRPM7 (also known as TRP-PLIK), a bifunctional protein that combines calcium- and magnesium-permeable cation channel properties with protein kinase activity. TRPM6 is expressed in intestinal epithelia and kidney tubules. These findings indicate that TRPM6 is crucial for magnesium homeostasis and implicate a TRPM family member in human disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032568     DOI: 10.1038/ng889

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  250 in total

Review 1.  Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle.

Authors:  Scott Earley
Journal:  Microcirculation       Date:  2010-05       Impact factor: 2.628

2.  Magnesium disorders: clinical experience and review of the literature.

Authors:  Maria Laura De Feo
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

3.  Optical recording reveals novel properties of GSK1016790A-induced vanilloid transient receptor potential channel TRPV4 activity in primary human endothelial cells.

Authors:  Michelle N Sullivan; Michael Francis; Natalie L Pitts; Mark S Taylor; Scott Earley
Journal:  Mol Pharmacol       Date:  2012-06-11       Impact factor: 4.436

Review 4.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 5.  Role of renal TRP channels in physiology and pathology.

Authors:  Viktor Tomilin; Mykola Mamenko; Oleg Zaika; Oleh Pochynyuk
Journal:  Semin Immunopathol       Date:  2015-09-18       Impact factor: 9.623

Review 6.  Invertebrate TRP proteins as functional models for mammalian channels.

Authors:  Joris Vriens; Grzegorz Owsianik; Thomas Voets; Guy Droogmans; Bernd Nilius
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

7.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

8.  Two novel genotypes of the thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in patients with Gitelman's syndrome.

Authors:  Noriko Aoi; Tomohiro Nakayama; Yoshiko Tahira; Akira Haketa; Minako Yabuki; Tadataka Sekiyama; Chie Nakane; Hiroaki Mano; Hideomi Kawachi; Naoyuki Sato; Masayoshi Soma; Kouichi Matsumoto
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

Review 9.  TRP channels and mice deficient in TRP channels.

Authors:  Bimal N Desai; David E Clapham
Journal:  Pflugers Arch       Date:  2005-08-03       Impact factor: 3.657

Review 10.  Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis.

Authors:  Vladimir Chubanov; Thomas Gudermann; Karl P Schlingmann
Journal:  Pflugers Arch       Date:  2005-06-17       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.